WHO International Health Regulations (IHR) vs COVID-19 Uncertainty
Main Article Content
Keywords
COVID 19, WHO
Abstract
One of WHO primary function is to control and monitor internationally the spread of infectious diseases of the common killers. After SARS-COV, the International Health Regulations (IHR) was adopted in 2005 by all 194 member states to set up national preparedness for an efficient “early alert and response system”. COVID-19 is a novel virus with an unpredictable course and many uncertainties about its biological, clinical and epidemiological characteristics. COVID-19 is a game changer and calls for a revision of IHR as well as a more biological, clinical and community-cantered preparedness strategy.
Downloads
References
2. Markel, H. (2014). Worldly approaches to global health: 1851 to the present. Public Health, 128(2), 124–128.
3. Stern A, Markel H. International efforts to control infectious diseases, 1851 to the present. J Am Med Assoc, 2004;292(12):1474e9.
4. Gostin LO. International infectious disease law: revision of the World Health Organization’s international health regulations. J Am Med Assoc 2004;291(21):2623e7.
5. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 (based on data as of the 31 December 2003) http://www.who.int/csr/sars/country/table2004_04_21/en
7. WHO, Checklist and Indicators for monitoring progress in the development of IHR capacities in States Parties, WHO Geneva, WHO/HSE/IHR/2010.1.Rev.1, February 2011
8. Stuckelberger Astrid, Synthesis of the instructional design and education material developed by the University of Geneva for the WHO IHR implementation training and i-Course from 2009 to 2012, Internal document, University of Geneva: Switzerland.
9. Kandel, Nirmal et al, Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries, The Lancet, 28 March 2020, Volume 395 (10229): 1047 - 1053
10. Gostin LO, Katz R. The International Health Regulations: The Governing Framework for Global Health Security. Milbank Q. 2016;94(2):264–313. doi:10.1111/1468-0009.12186
11. Kahn, Jeffrey S. MD, PhD*; McIntosh, Kenneth MD† History and Recent Advances in Coronavirus Discovery, The Pediatric Infectious Disease Journal: November 2005, Volume 24 - Issue 11 - p S223-S227
12. Haagmans BL, Albert DME, Osterhaus, in Vaccines for Biodefense and Emerging and Neglected Diseases, 2009, Chapter 36: 671-683.
13. Poutanen SM, Human Coronaviruses, Editor(s): Sarah S. Long, Charles G. Prober, Marc Fischer, In Principles and Practice of Pediatric Infectious Diseases (Fifth Edition), Elsevier, 2018, Chapter 222 (III, B): 1148-1152.
14. Katz R, Dowell SF, Revising the International Health Regulations: call for a 2017 review conference, The Lancet, Vol 3: e352-e353.
15. Cucinotta D, Vanelli M, WHO Declares COVID-19 a Pandemic, Acta Biomedica, 2020, Vol. 91(1): 157-160.
16. Eisenberg J, R0: How Scientists Quantify the Intensity of an Outbreak Like Coronavirus and Its Pandemic Potential, The Conversation, Michigan University School of Public Health, 27 March 2020. https://sph.umich.edu/pursuit/2020posts/how-scientists-quantify-outbreaks.html
17. Zhao et al., Relationship between the ABO Blood Group and the COVID-19 Susceptibility, medRxiv, 11 March 2020, 20031096. https://www.medrxiv.org/content/10.1101/2020.03.11.20031096v2
18 Gandhi M, P.H., Yokoe D S, Havlir DV, Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19, New England Journal of Medicine, Editorial, published online on 24 April 2020. https://www.nejm.org/doi/full/10.1056/NEJMe2009758
19. United Nations, Protecting Humanity from Future Health Crises, Report of the High-level Panel on the Global Response to Health Crises, Global Health Crisis Task Force, 7th Session of the UN General Assembly, A/70/723, Item 125: Global health and foreign policy, 2016. https://www.un.org/en/global-health-crises-task-force/
Article Sidebar
Article Details
How to Cite
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.